Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
About this study
This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.
- Condition
- Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
- Tested
- ADAPTS (ADherence Assessments and Personalized Timely Support).
- Sponsor
- Northwestern University
Who can join
- Age
- 14 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 16
- Minimum age: 14 years
- Study condition: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
- AYA Inclusion Criteria:
- Ages 14-29
- Diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
- In the maintenance phase, completed at least one cycle and has at least one month of maintenance therapy remaining.
- Prescribed 6-mercaptopurine (6MP)
- English language proficiency
- For AYA \<18, must have informed consent from their caregiver.
- AYA Exclusion Criteria:
- Cognitive impairments that would limit ability to complete measures, determined by the medical team
- Absence of inclusion criteria above.
- Caregiver Inclusion Criteria:
- Nominated by the AYA as a primary caregiver involved in cancer care (can be a parent, relative, partner, friend)
- Caregiver Exclusion Criteria:
- \- Absence of inclusion criteria above.
Where
1 site, 1 recruiting
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
Contact
-
Alexandra M Psihogios, Ph.D.
312-503-3577 alex.psihogios@northwestern.edu
Potential match only. Final eligibility is determined by the study team.